does glp 1 affect kidneys Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation Renal effects of GLP-1 receptor

Metabolic Disorders The recommended dose is 50 mg/kg given as a slow 2 to 3 minute bolus injection or by infusion

BLL Peptides BPC-157 is USA-manufactured and produced to pharmaceutical-grade standards with 98% purity verified by HPLC testing

a more favorable option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS Reference: rxlist.com (Tanzeum) Dulaglutide Drug Name: Trulicity (FDA Approved 9/18/14) GLP-1 receptor agonist, hypoglycemic Pharmacokinetics: Long acting (half life: 5 days) subcutaneous pen injections weekly dosing (vs daily dosing for some other GLP-1 agonists such as exenatide, liraglutide & lixisenatide) a more favorable dosing option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)

Although NR has shown promising results in this context, further studies are necessary to establish the efficacy and safety of NR in HF patients

& Giaccia, A